Evaluation of the Safety and Effectiveness of Aceclidine (LNZ101) and Aceclidine + Brimonidine (LNZ100) in the Treatment of Presbyopia
Clinical trial NCT05431543 · COMPLETED
Trial details
- NCT number
- NCT05431543
- Sponsor
- LENZ Therapeutics, Inc
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2022-08-06
- Primary completion
- 2022-12-14
- Enrollment
- 59
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.